TCP
RPTP

Tourbillon Capital Partners’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Tourbillon Capital Partners’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,264,999
Closed -$6.58M – 99
2015
Q4 		$6.58M Sell
1,264,999
-235,001
-16% -$1.36M 0.15% 65
2015
Q3 		$9.07M Buy
+1,500,000
New +$18.4M 0.24% 75

Other funds holding RPTP

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tourbillon Capital Partners's RPTP Position: Q1 2016 in Review

Tourbillon Capital Partners sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q1 2016, closing a stake of 1,264,999 shares — an estimated $6.58M sold.

Tourbillon Capital Partners first reported a position in RPTP in Q3 2015 and held it in 2 quarters. The position peaked at $9.07M in Q3 2015. 97 funds tracked by Wall St. Rank hold RPTP as of Q1 2016.

  • Tourbillon Capital Partners reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q1 2016 after selling out during the quarter.
  • Tourbillon Capital Partners sold 1,264,999 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q1 2016, an estimated $6.58M.
  • Tourbillon Capital Partners first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q3 2015 and held it in 2 quarters.
  • Tourbillon Capital Partners's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $9.07M in Q3 2015.
  • 97 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q1 2016.

Based on Tourbillon Capital Partners's 13F filing for Q1 2016, filed 16 May 2016.